Elemental Enzymes, a St. Louis biotechnology firm, has obtained a patent for a natural peptide solution to treat citrus greening disease.
The peptide solution, Vismax, is readying for commercialization and is expected to reach the market by 2022. Vismax has been developed and extensively field tested, says Brian Thompson, CEO of Elemental Enzymes.
Thompson gave a presentation on Nov. 18 during a Citrus Research and Development Foundation (CRDF) virtual seminar on peptides. He provided an overview of immune-activating peptides and their use in agriculture.
Peptides are linked chains of amino acids that aid in managing the bacterium that causes citrus greening. According to Thompson, using natural, non-toxic peptides to …..
Learn more about Field-Tested Peptide Treats Citrus Greening on the Citrus Industry website.